ARTG 470225Radionuclide system, therapeutic, stereotactic radiosurgery, application program software
ARTG ID: 470225 · Emergo Asia Pacific Pty Ltd T/a Emergo Australia · Cascination AG · Class IIb · Started November 25, 2024
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - Radionuclide system, therapeutic, stereotactic radiosurgery, application program software
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 470225
- Start Date
- November 25, 2024
- Effective Date
- November 25, 2024
- Name
- Cascination AG
- Country
- Switzerland
- Address
- Steigerhubelstrasse 3, Bern, 3008
Medical device software intended for image-based planning, instrument guidance and verification during CT-guided percutaneous interventions.
Access comprehensive regulatory information for Radionuclide system, therapeutic, stereotactic radiosurgery, application program software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 470225 and sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by Cascination AG in Switzerland. The device registration started on November 25, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.